Literature DB >> 17313497

Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.

Franco Trevisani1, Giulia Magini, Valentina Santi, Antonio Maria Morselli-Labate, Maria Chiara Cantarini, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gianludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Mauro Bernardi.   

Abstract

OBJECTIVES: Although the etiology of liver disease affects the features of hepatocellular carcinoma (HCC) diagnosed during surveillance, it is not known whether it influences patients' survival. We analyzed the impact of etiology on the characteristics and outcome of HCC detected during surveillance.
METHODS: In this cohort study, 742 patients with HCC detected during semiannual or annual surveillance were selected from the ITA.LI.CA database, including 1,834 consecutive patients observed in three primary and seven tertiary care settings for HCC. Patients were grouped according to etiology: hepatitis B virus (HBV, 87), hepatitis C virus (HCV, 461), alcohol (59), and multietiology (135).
RESULTS: In all etiologic groups, most HCCs were unifocal (51-68%) and most of them were <or=3 cm (60-69%). Unifocal HCCs were less common in the multietiology group (P=0.050) and slightly more frequent in the HCV group (P=0.087). Besides etiology, only age was associated with gross pathology (P=0.023). About two-thirds of HCCs in all groups were discovered at Cancer of the Liver Italyn Program (CLIP) stage 0 or 1. The 1-, 3-, and 5-yr survival rates were comparable among groups (HBV 81%, 47%, and 22%; HCV 86%, 49%, and 24%; alcohol 76%, 41%, and 25%; multietiology 75%, 37%, and 24%; P=0.446). The surveillance interval did not influence survival, which was independently predicted by serum alpha-fetoprotein, Child-Pugh class, gross pathology, cancer size, vascular invasion, and treatment.
CONCLUSION: In patients with HCC diagnosed during surveillance: (a) single nodules are less common in multietiology cases and (b) prognosis is independent of etiology, being dictated by liver function, oncologic features, and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17313497     DOI: 10.1111/j.1572-0241.2007.01100.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

1.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

2.  Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.

Authors:  Luigi Fenoglio; Cristina Serraino; Elisabetta Castagna; Adele Cardellicchio; Fulvio Pomero; Maurizio Grosso; Carlo Senore
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

3.  Hepatocellular carcinoma: prevention and therapy.

Authors:  Davendra P S Sohal; Weijing Sun
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

5.  Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.

Authors:  Myron J Tong; Hai-En Sun; Carlos Hsien; David S K Lu
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

6.  Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.

Authors:  Bin Jin; Zhiwei Gong; Nongguo Yang; Zhaoquan Huang; Sien Zeng; Hui Chen; Sanyuan Hu; Guangdong Pan
Journal:  Tumour Biol       Date:  2015-11-23

7.  Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.

Authors:  Kumardeep Chaudhary; Olivier B Poirion; Liangqun Lu; Lana X Garmire
Journal:  Clin Cancer Res       Date:  2017-10-05       Impact factor: 12.531

8.  Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.

Authors:  Teh I Huo; Chia Y Hsu; Yi H Huang; Chien W Su; Han C Lin; Rheun C Lee; Yi Y Chiou; Jen H Chiang; Pui C Lee; Shou D Lee
Journal:  BMC Gastroenterol       Date:  2010-12-31       Impact factor: 3.067

9.  Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.

Authors:  Amna Subhan Butt; Saeed Hamid; Ashfaq Ahmad Wadalawala; Mariam Ghufran; Ammar Asrar Javed; Omer Farooq; Bilal Ahmed; Tanveer Ul Haq; Wasim Jafri
Journal:  BMC Res Notes       Date:  2013-04-08

10.  Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data.

Authors:  Martin C S Wong; Johnny Y Jiang; Jin-ling Tang; Augustine Lam; Hong Fung; Stewart W Mercer
Journal:  BMC Health Serv Res       Date:  2008-06-25       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.